Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure

Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure

The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure.

Heart Transplant Miracle: From Box to Life in Palermo

2024-07-02 10:18:00 The Future of Heart Transplants: Innovations and Insights from the “Heart in the Box”… The post Heart Transplant Miracle: From Box to Life in Palermo appeared first on TIme News.

Driving Scientific Research and Medical Innovation - Science in Vancouver

The Centre for Heart Lung Innovation (HLI) is proud to celebrate the achievements of 3 principal investigators who have been awarded funding through the Canadian Institutes of Health Research (CIHR) Project Grants, Fall 2024 competition. This funding will drive innovative research in cardiovascular health, infection and immunity, and transplant medicine, advancing scientific discovery and improving patient outcomes.

In this episode Hans-Dieter Höltje and Bernd Rupp talk about active ingredients for the treatment of heart disease such as heart failure and angina pectoris. Structure of digoxin. OH group in position 12 distinguishes digoxin from digitoxin; source: Hans-Dieter Höltje. First they deal with the heart-effective glycosides and phosphodiesterase inhibitors. These substances increase the calcium ion concentration in the heart muscle cells, which lead…

Breakthrough research offers hope for treatment of ischemic heart...

Last Updated on March 9, 2025 by New York, March 9 (IANS) A global team of researchers has reported a groundbreaking discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in the journal npj Regenerative Medicine, the study by Baylor College of Medicine in the US, the QIMR […] The post Breakthrough research offers hope for treatment of ischemic heart failure appeared first on THIP Media.